Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $1.1 million.

  • Prime Medicine's Interest & Investment Income rose 63.70% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 86.02%. This contributed to the annual value of $3.5 million for FY2024, which is 25.29% up from last year.
  • Prime Medicine's Interest & Investment Income amounted to $1.1 million in Q3 2025, which was up 53.57% from $743,000 recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Interest & Investment Income registered a high of $1.5 million during Q4 2024, and its lowest value of $410,000 during Q3 2023.
  • Over the past 3 years, Prime Medicine's median Interest & Investment Income value was $720,000 (recorded in 2024), while the average stood at $876,400.
  • Within the past 5 years, the most significant YoY rise in Prime Medicine's Interest & Investment Income was 213.24% (2024), while the steepest drop was 52.08% (2024).
  • Over the past 3 years, Prime Medicine's Interest & Investment Income (Quarterly) stood at $491,000 in 2023, then spiked by 213.24% to $1.5 million in 2024, then surged by 63.70% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $743,000 for Q2 2025, and $1.2 million during Q1 2025.